DNA test may help predict likelihood of heart disease

By ľ¹ÏÖ±²¥ News

DNA sequencing.

The idea of using a person's entire DNA sequence to predict heart disease got a boost from a new study that successfully used the method.

The study used a genetic assessment called a polygenic risk score, or PRS, which looks at many variations in DNA that influence disease.

Use of polygenic risk scores is considered one of the most promising advances in heart disease research. Previous studies successfully applied them to a pool of people of European ancestry. The new study, which appeared Tuesday in the ľ¹ÏÖ±²¥'s journal , looked at a separate group of people, in this case French Canadians.

"The PRS is like having a snapshot of the whole genetic variation found in one's DNA" and can "powerfully" predict disease risk, lead author Guillaume Lettre said of the study in a news release.

His study looked at 3,639 French Canadian adults with cardiovascular disease and 7,382 adults without heart disease. The study showed the scores can identify 6% to 7% of people at high risk for cardiac disease.

Early detection could mean an early start to simple, effective treatment such as statins, aspirin or other medications.

The scores, however, did not do a good job of predicting new heart attacks in people who had already had one.

Lettre, an associate professor at the Montreal Heart Institute and Université de Montréal in Canada, said the next step is for large clinical studies to determine whether treating people based on risk scores improves their heart health. Researchers also need to determine how to integrate the scores with known risk factors, such as blood pressure, diabetes and cholesterol levels, and to extend these studies to non-European ancestry populations, he said.

"This research is exciting, as genetic testing is becoming more powerful, affordable and it's easy – often requiring only a swab of one's saliva," Lettre said.

If you have questions or comments about this story, please email [email protected].


ľ¹ÏÖ±²¥ News Stories

ľ¹ÏÖ±²¥ News covers heart disease, stroke and related health issues. Not all views expressed in ľ¹ÏÖ±²¥ News stories reflect the official position of the ľ¹ÏÖ±²¥. Statements, conclusions, accuracy and reliability of studies published in ľ¹ÏÖ±²¥ scientific journals or presented at ľ¹ÏÖ±²¥ scientific meetings are solely those of the study authors and do not necessarily reflect the ľ¹ÏÖ±²¥â€™s official guidance, policies or positions.

Copyright is owned or held by the ľ¹ÏÖ±²¥., and all rights are reserved. Permission is granted, at no cost and without need for further request, for individuals, media outlets, and non-commercial education and awareness efforts to link to, quote, excerpt from or reprint these stories in any medium as long as no text is altered and proper attribution is made to ľ¹ÏÖ±²¥ News.

Other uses, including educational products or services sold for profit, must comply with the ľ¹ÏÖ±²¥â€™s Copyright Permission Guidelines. See full terms of use. These stories may not be used to promote or endorse a commercial product or service.

HEALTH CARE DISCLAIMER: This site and its services do not constitute the practice of medical advice, diagnosis or treatment. Always talk to your health care provider for diagnosis and treatment, including your specific medical needs. If you have or suspect that you have a medical problem or condition, please contact a qualified health care professional immediately. If you are in the United States and experiencing a medical emergency, call 911 or call for emergency medical help immediately.